Recent advances in the design of drug-loaded polymeric implants for the treatment of solid tumors

Ameena Wadee1, Viness Pillay, Yahya E Choonara

  • 1University of the Witwatersrand, Department of Pharmacy and Pharmacology, Parktown, 2193, Johannesburg, South Africa.

Abstract

Insights

Polymeric implants offer localized chemotherapy delivery for solid tumors, reducing side effects. While promising, the ideal implant for sustained, high-dose delivery with minimal toxicity is still under development.

Area of Science:

  • Biomaterials Science
  • Oncology
  • Drug Delivery Systems

Background:

  • Solid tumor treatment remains challenging despite novel drug development.
  • Localized chemotherapy delivery aims to improve efficacy and reduce patient side effects.
  • In situ forming implants are gaining interest as a minimally invasive drug delivery method.

Purpose of the Study:

  • To review the development of polymeric implants for solid tumor treatment.
  • To discuss both in situ forming and preformed implant strategies.
  • To cover peri- or intra-tumoral delivery and initial burst release effects.

Main Methods:

  • Review of literature on polymeric implants for solid tumors.
  • Description of in situ forming and preformed implants (natural and synthetic polymers).
  • Discussion of surgical implantation and chemotherapeutic agent delivery.

Main Results:

  • Polymeric implants have demonstrated potential in improving solid tumor treatment.
  • Both in situ forming and preformed implants are viable strategies.
  • Initial burst release can be an undesirable characteristic of some implants.

Conclusions:

  • Current implants show promise but have not yet achieved ideal characteristics.
  • The ideal implant should provide sustained, high-dose chemotherapy to tumors.
  • Minimizing side effects on normal tissues remains a critical goal for future implant development.

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...